Table 3.
Postoperative outcomes of all included patients (n = 664)
| Variable | Value |
|---|---|
| Adjuvant therapy | 473 (71.23) |
| Chemotherapy | 330 (49.70) |
| Targeted therapy | 65 (9.79) |
| Chemotherapy + anti-angiogenic therapy | 24 (3.61) |
| Chemotherapy + radiotherapy | 23 (3.46) |
| Chemotherapy + targeted therapy | 8 (1.20) |
| Other | 23 (3.46) |
| Recurrence rate at the last follow-up time | 247 (37.20) |
| Recurrence site (for all patients with recurrence) | |
| Lung | 111 (50.45) |
| Brain | 55 (25.00) |
| Skeleton | 43 (19.54) |
| Liver | 19 (8.64) |
| Lymph node | 15 (6.82) |
| Other | 41 (18.64) |
| Recurrence-free survival probability, % | |
| 1.0 year | 74.1 |
| 2.0 years | 57.4 |
| 3.0 years | 43.5 |
| 5.0 years | 26.4 |
| Overall survival (months), median (95% c.i.) | 60.0 (51.5,67.6) |
| Overall survival probability, % | |
| 1.0 year | 89.6 |
| 2.0 years | 77.8 |
| 3.0 years | 67.2 |
| 5.0 years | 49.0 |
| Survival status | |
| Death | 202 (30.42) |
| Live | 372 (56.02) |
| Missing | 90 (13.55) |
Values are n (%) unless otherwise indicated.